New cancer clinical trial: Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies

Published on: August 31, 2018 at 12:00PM
Condition:   Head and Neck Cancer
Intervention:   Drug: Apatinib
Sponsors:   China International Medical Foundation;   Chinese Society of Clinical Oncology
Not yet recruiting
https://ift.tt/2PpWtZQ